Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Maxinovel's Orally Active PD-L1 Inhibitor Demonstrating Similar Efficacy to PD-L1 Antibody Durvalumab

firstwordpharmaApril 21, 2019

Tag: Maxinovel , Orally Active , PD-L1 inhibitor

PharmaSources Customer Service